Bacteriophages (or simply, phages) are the most abundant microorganisms on earth. They are natural adversaries to bacteria. They can be found in soil, the human organism, food, water, etc. Phages aptly target specific bacteria. They do not affect human, animal, or plant cells; hence the unprecedented safety of phage therapy.
Biochimpharm is a biotechnological company engaged in the research, development, and commercialization of phages. For decades, we have been deploying bacteriophage technology to create natural, safe, and effective preparations. Nowadays, phage preparations are the only viable alternative to antibiotics. Our products are effectively used for the treatment and prevention of infections caused by resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). Unlike other antimicrobial preparations, such as antibiotics, phages selectively eliminate disease-causing bacteria without harming the beneficial microflora of the human body. Phages do not have any contraindications or side effects, such as adverse effects on the liver and kidneys, dysbacteriosis, and other problems ensuing from antibiotic use.
Biochimpharm is founded on a scientific and technological basis of the Eliava Institute of Bacteriophages, which had been providing all of the Soviet Union and Eastern Europe with phages for fifty years. We are drawing on one hundred years of accumulated experience in the research and manufacture of phages. Biochimpharm is one of the world leaders in the field of bacteriophage technology; Its coverage area extending year by year.
VISION AND MISSION
Our mission is to eradicate the irrational use of antibiotics and overcome resistant infections.
Nature is a perfectly arranged system. Being part of this arrangement, each and every natural organism has its point of existence, contributing to the perfection of this system. Phages eliminate bacteria; doing so with extraordinary accuracy, without damaging anything else.
We apply phage technology for a secure life and health.
When it was still a part of the Eliava Institute of Bacteriophages, scientists and technologists forming “Phage Enterprise” had been researching and manufacturing curative and preventive preparations from as early as the 1940s. This is the scientific and technological basis, which Biochimpharm is founded on. In 1994, “Phage Enterprise” separated from the institute and was established as a private organization. In November 1999, the company name was changed to JSC “Biochimpharm”.
The experience in the field of bacteriophages, accumulated during the Soviet period, is maintained within the enterprise. From the very beginning, based on traditional preparations, the Biochimpharm team has been researching and elaborating on new forms of medicine, such as liquid, spray, capsule and tablet; also, creating new, innovative preparations for overcoming emerging diseases caused by resistant bacterial pathogens.
Biochimpharm products are present on local and export markets; On all of them, our products are distributed in pharmacies, with no prescription required.
We are an ISO 9001:2015 certified company, holding a diploma in ecology and safe technology of the EU.
Apart from other achievements, Biochimpharm is a winner in “The Leader of the field 2015” nomination of National Business Ratings Union. The company was also prized as “The Innovative Business 2016” at Georgian Business Awards.